218 related articles for article (PubMed ID: 32736189)
1. Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.
Teixeira JM; Abdalla HB; Basting RT; Hammock BD; Napimoga MH; Clemente-Napimoga JT
Int Immunopharmacol; 2020 Oct; 87():106841. PubMed ID: 32736189
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase inhibitor, TPPU, increases regulatory T cells pathway in an arthritis model.
Trindade-da-Silva CA; Clemente-Napimoga JT; Abdalla HB; Rosa SM; Ueira-Vieira C; Morisseau C; Verri WA; Montalli VAM; Hammock BD; Napimoga MH
FASEB J; 2020 Jul; 34(7):9074-9086. PubMed ID: 32400048
[TBL] [Abstract][Full Text] [Related]
3. Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.
Zhou Y; Yang J; Sun GY; Liu T; Duan JX; Zhou HF; Lee KS; Hammock BD; Fang X; Jiang JX; Guan CX
Cell Tissue Res; 2016 Feb; 363(2):399-409. PubMed ID: 26310139
[TBL] [Abstract][Full Text] [Related]
4. Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption.
Napimoga MH; Rocha EP; Trindade-da-Silva CA; Demasi APD; Martinez EF; Macedo CG; Abdalla HB; Bettaieb A; Haj FG; Clemente-Napimoga JT; Inceoglu B; Hammock BD
J Periodontal Res; 2018 Oct; 53(5):743-749. PubMed ID: 29851077
[TBL] [Abstract][Full Text] [Related]
5. 1-Trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) Urea, a Selective and Potent Dual Inhibitor of Soluble Epoxide Hydrolase and p38 Kinase Intervenes in Alzheimer's Signaling in Human Nerve Cells.
Liang Z; Zhang B; Xu M; Morisseau C; Hwang SH; Hammock BD; Li QX
ACS Chem Neurosci; 2019 Sep; 10(9):4018-4030. PubMed ID: 31378059
[TBL] [Abstract][Full Text] [Related]
6. Soluble epoxide hydrolase inhibition decreases reperfusion injury after focal cerebral ischemia.
Tu R; Armstrong J; Lee KSS; Hammock BD; Sapirstein A; Koehler RC
Sci Rep; 2018 Mar; 8(1):5279. PubMed ID: 29588470
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Inhibition of Soluble Epoxide Hydrolase Ameliorates Chronic Ethanol-Induced Cardiac Fibrosis by Restoring Autophagic Flux.
Zhou C; Huang J; Li Q; Zhan C; He Y; Liu J; Wen Z; Wang DW
Alcohol Clin Exp Res; 2018 Oct; 42(10):1970-1978. PubMed ID: 30047995
[TBL] [Abstract][Full Text] [Related]
8. Soluble Epoxide Hydrolase Inhibitor Suppresses the Expression of Triggering Receptor Expressed on Myeloid Cells-1 by Inhibiting NF-kB Activation in Murine Macrophage.
Dong L; Zhou Y; Zhu ZQ; Liu T; Duan JX; Zhang J; Li P; Hammcok BD; Guan CX
Inflammation; 2017 Feb; 40(1):13-20. PubMed ID: 27696333
[TBL] [Abstract][Full Text] [Related]
9. The contribution of chymase-dependent formation of ANG II to cardiac dysfunction in metabolic syndrome of young rats: roles of fructose and EETs.
Froogh G; Kandhi S; Duvvi R; Le Y; Weng Z; Alruwaili N; Ashe JO; Sun D; Huang A
Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H985-H993. PubMed ID: 32167781
[TBL] [Abstract][Full Text] [Related]
10. Soluble Epoxide Hydrolase Pharmacological Inhibition Decreases Alveolar Bone Loss by Modulating Host Inflammatory Response, RANK-Related Signaling, Endoplasmic Reticulum Stress, and Apoptosis.
Trindade-da-Silva CA; Bettaieb A; Napimoga MH; Lee KSS; Inceoglu B; Ueira-Vieira C; Bruun D; Goswami SK; Haj FG; Hammock BD
J Pharmacol Exp Ther; 2017 Jun; 361(3):408-416. PubMed ID: 28356494
[TBL] [Abstract][Full Text] [Related]
11. Effects of sEH inhibition on the eicosanoid and cytokine storms in SARS-CoV-2-infected mice.
Edin ML; Gruzdev A; Graves JP; Lih FB; Morisseau C; Ward JM; Hammock BD; Bosio CM; Zeldin DC
FASEB J; 2024 May; 38(10):e23692. PubMed ID: 38786655
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys.
Ulu A; Appt S; Morisseau C; Hwang SH; Jones PD; Rose TE; Dong H; Lango J; Yang J; Tsai HJ; Miyabe C; Fortenbach C; Adams MR; Hammock BD
Br J Pharmacol; 2012 Mar; 165(5):1401-12. PubMed ID: 21880036
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole increases the efficacy of a soluble epoxide hydrolase inhibitor in a PGE₂ induced pain model.
Goswami SK; Inceoglu B; Yang J; Wan D; Kodani SD; da Silva CA; Morisseau C; Hammock BD
Toxicol Appl Pharmacol; 2015 Dec; 289(3):419-27. PubMed ID: 26522832
[TBL] [Abstract][Full Text] [Related]
14. Lectin from Abelmoschus esculentus reduces zymosan-induced temporomandibular joint inflammatory hypernociception in rats via heme oxygenase-1 pathway integrity and tnf-α and il-1β suppression.
Freitas RS; do Val DR; Fernandes ME; Gomes FI; de Lacerda JT; SantiGadelha T; de Almeida Gadelha CA; de Paulo Teixeira Pinto V; Cristino-Filho G; Pereira KM; de Castro Brito GA; Bezerra MM; Chaves HV
Int Immunopharmacol; 2016 Sep; 38():313-23. PubMed ID: 27344040
[TBL] [Abstract][Full Text] [Related]
15. sEH Inhibitor Tppu Ameliorates Cecal Ligation and Puncture-Induced Sepsis by Regulating Macrophage Functions.
Chen Z; Tang Y; Yu J; Dong R; Yang Y; Fu M; Luo J; Hu S; Wang DW; Tu L; Xu X
Shock; 2020 Jun; 53(6):761-771. PubMed ID: 31318834
[TBL] [Abstract][Full Text] [Related]
16. Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress.
Huang HJ; Wang YT; Lin HC; Lee YH; Lin AM
Mol Neurobiol; 2018 Jan; 55(1):138-144. PubMed ID: 28822080
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice.
Harris TR; Bettaieb A; Kodani S; Dong H; Myers R; Chiamvimonvat N; Haj FG; Hammock BD
Toxicol Appl Pharmacol; 2015 Jul; 286(2):102-11. PubMed ID: 25827057
[TBL] [Abstract][Full Text] [Related]
18. 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), a soluble epoxide hydrolase inhibitor, lowers L-NAME-induced hypertension through suppression of angiotensin-converting enzyme in rats.
Bukhari IA; Alorainey BI; Al-Motrefi AA; Mahmoud A; Campbell WB; Hammock BD
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8143-8150. PubMed ID: 32767352
[TBL] [Abstract][Full Text] [Related]
19. The indirect antinociceptive mechanism of 15d-PGJ2 on rheumatoid arthritis-induced TMJ inflammatory pain in rats.
Quinteiro MS; Napimoga MH; Mesquita KP; Clemente-Napimoga JT
Eur J Pain; 2012 Sep; 16(8):1106-15. PubMed ID: 22354681
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory treatment with a soluble epoxide hydrolase inhibitor attenuates seizures and epilepsy-associated depression in the LiCl-pilocarpine post-status epilepticus rat model.
Shen Y; Peng W; Chen Q; Hammock BD; Liu J; Li D; Yang J; Ding J; Wang X
Brain Behav Immun; 2019 Oct; 81():535-544. PubMed ID: 31306773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
